中商官网
研究报告
环球药业（835037）
主要经济指标
| 类别\年份 | 营业收入 （元) |
营业利润 （元) |
利润总额 （元) |
净利润 （元) |
资产总计 （元) |
负债合计 （元) |
股东权益合计 （元) |
| 2013 | 206000000.0000 | 39620900.0000 | 43707300.0000 | 37684300.0000 | 262000000.0000 | 90050100.0000 | 172000000.0000 |
| 2014 | 207000000.0000 | 39110900.0000 | 39194400.0000 | 33853900.0000 | 292000000.0000 | 96167600.0000 | 196000000.0000 |
| 2015 | 188000000.0000 | 32441300.0000 | 38361600.0000 | 33336800.0000 | 301000000.0000 | 82266700.0000 | 219000000.0000 |
| 2016 | 221000000.0000 | 32494500.0000 | 36490800.0000 | 31811700.0000 | 333000000.0000 | 91719300.0000 | 241000000.0000 |
| 2017 | 268000000.0000 | 35024500.0000 | 33972600.0000 | 30204900.0000 | 340000000.0000 | 83952800.0000 | 256000000.0000 |
| 2018 | 317000000.0000 | 41704400.0000 | 41336900.0000 | 37075400.0000 | 375000000.0000 | 82939100.0000 | 292000000.0000 |
| 2019 | 337000000.0000 | 57396200.0000 | 55913200.0000 | 48610600.0000 | 393000000.0000 | 81662700.0000 | 311000000.0000 |
| 2020 | 315000000.0000 | 71428500.0000 | 71409800.0000 | 62092900.0000 | 428000000.0000 | 89730500.0000 | 339000000.0000 |
| 2021 | 322000000.0000 | 81276400.0000 | 84892100.0000 | 74345600.0000 | 447000000.0000 | 82967800.0000 | 364000000.0000 |
| 2022 | 279000000.0000 | 61828600.0000 | 59588500.0000 | 52462100.0000 | 453000000.0000 | 86300900.0000 | 367000000.0000 |
| 2023 | 244000000.0000 | 72959000.0000 | 74335600.0000 | 64872900.0000 | 451000000.0000 | 68805100.0000 | 382000000.0000 |
| 2024 | 228000000.0000 | 79742100.0000 | 81086300.0000 | 70534600.0000 | 431000000.0000 | 67066200.0000 | 364000000.0000 |
盈利能力分析
| 类别\年份 | 销售毛利率 （%) |
营业利润率 （%) |
总资产利润率 （%) |
净资产收益率 | 存货周转率 | 应收账款周转率 （次) |
总资产周转率 （次) |
| 2013 | 18.93 | 21.22 | 16.68 | -- | 3.6300 | 4.25 | 0.79 |
| 2014 | 18.36 | 18.93 | 13.42 | -- | 3.5700 | 4.23 | 0.71 |
| 2015 | 17.02 | 20.41 | 12.74 | 16.2700 | 3.8300 | 3.76 | 0.62 |
| 2016 | 14.03 | 16.51 | 10.96 | 13.8800 | 4.6900 | 4.04 | 0.66 |
| 2017 | 10.45 | 12.68 | 9.99 | 12.2200 | 5.2200 | 4.07 | 0.79 |
| 2018 | 10.73 | 13.04 | 11.02 | 13.8600 | 4.2500 | -- | 0.85 |
| 2019 | 14.84 | 16.59 | 14.23 | 16.2600 | 4.2600 | 4.07 | 0.86 |
| 2020 | 18.73 | 22.67 | 16.68 | 19.2900 | 4.5200 | 4.07 | 0.74 |
| 2021 | 17.39 | 26.36 | 18.99 | 21.1800 | 4.6900 | 4.62 | 0.72 |
| 2022 | 19.35 | 21.36 | 13.15 | 14.6900 | 4.2400 | 4.82 | 0.62 |
| 2023 | 26.64 | 30.47 | 16.48 | 17.7000 | 3.8200 | 5.17 | 0.54 |
| 2024 | 32.46 | 35.56 | 18.81 | 19.6700 | 3.6400 | 5.57 | 0.53 |
偿债能力分析
| 类别\年份 | 资产负债率 （%) |
股东权益比率 （%) |
流动比率 | 速动比率 |
| 2013 | 34.37 | 65.65 | 2.6100 | 2.0200 |
| 2014 | 32.93 | 67.12 | 2.4300 | 2.0100 |
| 2015 | 27.33 | 72.76 | 3.2300 | 2.8000 |
| 2016 | 27.54 | 72.37 | 3.3800 | 2.9600 |
| 2017 | 24.69 | 75.29 | 3.8100 | 3.2500 |
| 2018 | 22.12 | 77.87 | 4.7300 | 3.6100 |
| 2019 | 20.78 | 79.13 | 5.0900 | 4.4500 |
| 2020 | 20.97 | 79.21 | 4.9200 | 4.4100 |
| 2021 | 18.56 | 81.43 | 5.2900 | 4.8100 |
| 2022 | 19.05 | 81.02 | 2.1400 | 1.6500 |
| 2023 | 15.26 | 84.70 | 2.7900 | 2.3200 |
| 2024 | 15.56 | 84.45 | 5.0700 | 1.1700 |
成本费用分析
| 类别\年份 | 营业成本 （元) |
销售费用 （元) |
管理费用 （元) |
财务费用 （元) |
| 2013 | 167000000.0000 | 46552600.0000 | 18999800.0000 | 75100.0000 |
| 2014 | 169000000.0000 | 52644600.0000 | 18367300.0000 | 47100.0000 |
| 2015 | 156000000.0000 | 45940400.0000 | 19657100.0000 | 33500.0000 |
| 2016 | 190000000.0000 | 67269200.0000 | 19397500.0000 | 14800.0000 |
| 2017 | 240000000.0000 | 87434600.0000 | 11240400.0000 | 9900.0000 |
| 2018 | 283000000.0000 | 106000000.0000 | 16768200.0000 | 36600.0000 |
| 2019 | 287000000.0000 | 111000000.0000 | 10005400.0000 | 32900.0000 |
| 2020 | 256000000.0000 | 88709300.0000 | 10306400.0000 | 131100.0000 |
| 2021 | 266000000.0000 | 90635900.0000 | 11486500.0000 | 79200.0000 |
| 2022 | 225000000.0000 | 71882400.0000 | 10619700.0000 | 32900.0000 |
| 2023 | 179000000.0000 | 57140400.0000 | 10750500.0000 | 32900.0000 |
| 2024 | 154000000.0000 | 42688800.0000 | 11065300.0000 | 32900.0000 |